Synacthen (Tetracosactrin) ( DrugBank: Tetracosactrin )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 78 | Hypopituitarism | 1 |
78. Hypopituitarism
Clinical trials : 494 / Drugs : 385 - (DrugBank : 49) / Drug target genes : 44 - Drug target pathways : 100
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00851942 (ClinicalTrials.gov) | September 2008 | 25/2/2009 | Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test | Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test | Healthy;Adrenal Insufficiency;Hypopituitarism | Drug: Synacthen (Tetracosactrin) | Cardiff University | NULL | Completed | 18 Years | 80 Years | All | 165 | Phase 4 | United Kingdom |